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Abstract
Background: For an effective artificial pancreas (AP) system and an improved therapeutic intervention with
continuous glucose monitoring (CGM), predicting the occurrence of hypoglycemia accurately is very important. While
there have been many studies reporting successful algorithms for predicting nocturnal hypoglycemia, predicting
postprandial hypoglycemia still remains a challenge due to extreme glucose fluctuations that occur around
mealtimes. The goal of this study is to evaluate the feasibility of easy-to-use, computationally efficient
machine-learning algorithm to predict postprandial hypoglycemia with a unique feature set.
Methods: We use retrospective CGM datasets of 104 people who had experienced at least one hypoglycemia alert
value during a three-day CGM session. The algorithms were developed based on four machine learning models with a
unique data-driven feature set: a random forest (RF), a support vector machine using a linear function or a radial basis
function, a K-nearest neighbor, and a logistic regression. With 5-fold cross-subject validation, the average performance
of each model was calculated to compare and contrast their individual performance. The area under a receiver
operating characteristic curve (AUC) and the F1 score were used as the main criterion for evaluating the performance.
Results: In predicting a hypoglycemia alert value with a 30-min prediction horizon, the RF model showed the best
performance with the average AUC of 0.966, the average sensitivity of 89.6%, the average specificity of 91.3%, and the
average F1 score of 0.543. In addition, the RF showed the better predictive performance for postprandial
hypoglycemic events than other models.
Conclusion: In conclusion, we showed that machine-learning algorithms have potential in predicting postprandial
hypoglycemia, and the RF model could be a better candidate for the further development of postprandial
hypoglycemia prediction algorithm to advance the CGM technology and the AP technology further.
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Background
Intensive insulin treatment is a standard of care for
tight glycemic control in people with diabetes, to pre-
vent or delay long-term complications of diabetes mellitus
[1–3] However, insulin therapy may cause life threaten-
ing hypoglycemia and thus achieving and maintaining
near normoglycemia is largely limited by this risk factor
[4], which persists despite advances in treatment tech-
nique [2–6]. Recently, artificial pancreas (AP) systems
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are emerging and they use machine-learning algorithms
to reduce the frequency of hypoglycemic episodes, even
in the presence of intensive insulin treatment, and are
among the greatest advances in diabetes care in recent
development [7, 8].
In the clinically approved hybrid AP system, mealtime
insulin dosing depends on the carbohydrate counting
by patients. This process requires extensive patient edu-
cation and is a complex task to most patients, which
can lead to entering inaccurate information and con-
sequently miscalculation of insulin dosage [9]. For this
reason, the single-hormone AP system delivers a reduced
bolus insulin dose at mealtime, to avoid risk of postpran-
dial hypoglycemia. The systems then reduce the post-
meal hyperglycemia by increasing the infusion rate of
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basal insulin. This conservative dosing of mealtime bolus
insulin explains in part why only modest daytime ben-
efit has been achieved by the single-hormone AP sys-
tem, in spite of impressive nocturnal glucose control.
The recently proposed bi-hormonal AP system [6] con-
trols both insulin and glucagon pump to reduce hypo-
glycemia while maintaining intensive insulin treatment,
and thus does not require carbohydrate counting by
patients. However, the use of an additional glucagon
pump increases the system cost and complexity. Fur-
thermore, the use of these systems can cause nausea,
and raises long-term concerns about safety [10, 11]. It
has been reported that single- and bi-hormonal artifi-
cial pancreas systems indeed control nocturnal glucose
with equal effectiveness [12]. Despite the existence of
algorithms that predict nocturnal hypoglycemia (for both
single- and bi-hormonal AP systems) with high accu-
racy, the prediction of postprandial hypoglycemia is still a
challenge because of extreme glucose fluctuations around
mealtimes. Current rapid-acting insulin [13] analogues
are still not equivalent to physiologic biphasic insulin
secretion that precisely regulates the rapid changes in
glucose intake, glucagon secretion, endogenous glucose
production, and utilization of glucose around meal-
times[14]. This highlights the importance of developing
an accurate and easy to use algorithm to predict postpran-
dial hypoglycemia.
As a method for predicting a glucose level or the
occurrence of the hypoglycemia, a physiological pre-
diction method, a data-driven method, and a hybrid
method were proposed [15, 16]. Among them, many
data-driven models relying on continuous glucose mon-
itoring (CGM) data and additional inputs such as diet,
exercise, insulin injection dosage, and others have been
proposed [15]. Firstly, there have been several studies to
develop time series models [17–19] that can predict a
glucose level. Sparacino et al. [17] proposed a first-order
autoregressive (AR) and a first-order polynomial model
to predict a glucose level with 30-min or 45-min pre-
diction horizons. The proposed forgetting factor allowed
the models to be more sensitive to the recent CGM
data points, and thus the models were able to reflect
rapid glucose changes around mealtimes. However, the
models needed to tune their parameters at every sam-
pling and the predicted glucose fluctuated significantly
as the forgetting factor got smaller. An autoregressive
integrated moving-average (ARIMA)model with an adap-
tive algorithm was recently proposed [18]. When the
proposed model predicted hypoglycemia with the 30-
min prediction horizon, time of detection was earlier
and false alarm rate was lower than other models such
as an adaptive univariate model and a general ARIMA
model. However, this model requires large computa-
tions and is difficult to be implemented in real time.
Another time series model with exogenous inputs such
as meal information, insulin on board, and physical activ-
ity was recently proposed [19]. Although this model
showed impressive performance for an early prediction
of hypoglycemia, requirements for manual inputs makes
this solution cumbrous, difficult to use and prone for
errors [16].
Machine learning has made a great progress in medi-
cal data science and has been applied to a glucose level
or hypoglycemia prediction as well [15, 16, 20–28]. The
artificial neural network (ANN) proposed in [20] used
five consecutive CGMdata points andmeasurement time.
Although ANN showed better predictive performance
than time series model (e.g., AR model [17]), it could not
detect sudden changes in a glucose level due to meals or
insulin injections. However, this limitation could be over-
come by inserting additional information such as meals
[21–23] and insulin doses [23], but the cost of simplicity.
A feed-forward neural network model has been presented
in [24], but training this model also required burdensome
inputs such as insulin dosage, nutritional intake, lifestyle,
and emotional factor other than consecutive CGM data
points. In addition to the neural network approach, there
have been numerous efforts to predict hypoglycemia
with an ensemble method [25], a decision-tree method
[26, 27], and machine learning models using self-
monitoring blood glucose (BG) data [28]. However, most
of the related works required more than one form of man-
ual inputs for more accurate prediction of hypoglycemia
and did not focus on postprandial hypoglycemia except
for our preliminary study [27].
The goal of this study is to develop an easy-to-use,
computationally efficient machine-learning algorithm to
predict postprandial hypoglycemia using unique data-
driven features derived from the data. The glucose dynam-
ics in daytime and nighttime are quite different due
to meals and activities, and having a dedicated algo-
rithm for the postprandial hypoglycemia would improve
the AP’s insulin dosing during the daytime benefitting
the patient significantly. In addition, computationally effi-
cient algorithm, which does not require any parameter
tuning on new dataset, with the reduced number of man-
ual inputs will help the AP system to be more usable,
compact, and clinically feasible. We validated postpran-
dial hypoglycemia prediction with 30 min of the pre-
diction horizon using retrospective CGM dataset of 104
patients described in the data “Data acquisition” section.
As detailed in the “Methods” section, we used commonly
used machine learning models to compare and contrast
their individual performance, and finally determine the
best candidate for the further development of the post-
prandial hypoglycemia prediction algorithm for the future
AP system. In the next few subsections we present our
work in greater detail.
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Methods
Data acquisition
We reviewed the medical records of all 411 patients
who underwent CGM at Samsung Medical Center (Seoul,
Republic of Korea) between 2013 and 2015, with approval
from the Institutional Review Board (IRB) of the Sam-
sung Medical Center (IRB File number; SMC 2016-
05-058-001). All medical procedures were performed
in accordance with relevant guidelines and regulations.
The informed consent requirement for this study was
waived by the board because the researcher only accessed
the database for analysis purposes, and all patient data
were de-identified. From these records, we extracted
113 three-day CGM datasets from 110 Korean adults
(aged ≥18 y) that met two inclusion criteria: 1) the
CGM data contained at least one BG level ≤3.9 mmol/L
(70 mg/dL); and 2) the primary purpose of performing
CGM included evaluation of hypoglycemia. Of the 110
patients who met inclusion criteria, six were excluded:
two patients had alimentary hypoglycemia after total gas-
trectomy, two patients took acetaminophen during the
CGM, one patient had gestational diabetes and was not
taking any anti-diabetic medications or insulin (n=1),
and one patient had missing data. Of the remaining 104
patients (Table 1), 52 (aged 18-74 years) had type-1 dia-
betes mellitus and 52 (aged 32-80 years) had type-2 dia-
betes mellitus. During the study, none of the patients
was under steroid therapy with doses higher than a pred-
nisolone equivalent of 7.5 mg per day, and none was
under cancer treatment such as chemotheraphy or radio-
theraphy. One patient was undergoing treatment for dia-
betic foot infection. Three of the participants contributed
two separate three-day CGM datasets separated by 9 to
22 months, so a total of 107 three-day CGM datasets
were used.
The Medtronic’s CGMS GoldTM (Medtronic MiniMed,
Northridge, CA, USA) was used to collect continuous
glucose data for the durations of 72-96 h with subjects
blinded to the data. The CGMS Gold report indicated
mean absolute relative difference (MARD) values of 11 to
14%, and a continuous BG error grid plot analysis showed
percentage paired values in zone A (optimal) or zone B
(acceptable from a clinical/diabetological perspective) to
be 98% [29, 30]. BG trends and patterns were identified
by retrospective analysis of CGM data. To calibrate the
CGM sensors, finger-stick BG levels were measured more
than three times per day in all enrolled patients with each
measurement made right before each meal. Therefore, the
time points at which the BGmeasurements were recorded
for calibration purpose were regarded as the mealtime
for this study. The BG measurements within the noctur-
nal interval (11:00 PM - 7:00 AM) [31] were excluded for
the purpose of this study. In addition, if the time interval
between two successive BG measurements was less than
2 h, only the last measurement was considered as a meal
announcement.
We used Excel (Microsoft, Redmond, USA) to prepare
the CGM data and Matlab (Matlab release 2016b, The
MathWorks, Natick, 2016) to implement machine learn-
ing models and their analyses.
Data pre-processing and feature extraction
Each CGM time series was presented as a sequence where
the ith CGM time series is given by:
CGMi,: = {(CGMi,t) with t = 1, ...,Ni} (1)
where Ni is the length of CGMi,:. For each time series,
missing CGM data points were interpolated by the spline
method [20] only if less than 3 CGM data points were
missing consecutively. Themissing CGMdata points were
reported when the device fails its calibration process [32].
The CGM measurement is taken at every 5 min, and thus
CGMi,t=n means that the CGM data point at 5 × nth
minute of the ith CGM time series. In our study, we took
CGM data points after meal announcements and each
CGM data point is represented in Eq. 2.
CGMi,j,t = CGMi,meali,j+t with t ∈ {1, ...,W } (2)
where meali,j is the time of the jth meal announcement of
the ith CGM time series, andW is the postprandial period.
We first analyzed the CGM trends of all selected
patients’ data to identify meaningful features for post-
prandial hypoglycemia. A subset of patients experienced
postprandial hypoglycemia if they had a small peak or no
peak in CGM, probably due to the meal being small or
containing only a small portion of carbohydrate (Fig. 1a
and b). There was another group of patients experi-
enced hypoglycemia when the CGM increased steeply and
then dropped right after the peak; this reaction probably
occurred when the patients ingested carbohydrates with
high glycemic index or when the pre-meal rapid-acting
insulin was injected too late (Fig. 1c). Insulin injected
before a preceding meal can affect a glucose level after the
meal. In other cases, a decrease in CGM, in spite of meal
ingestion, may have been caused by the insulin on board
and was associated with future hypoglycemic episodes
(Fig. 1d).
We used above observed data points to define features
for predicting hypoglycemia near mealtime. The first fea-
ture is defined as ‘the rate of increase in glucose’ (RIG),
which is the rate of glucose increase from ameal to a peak:
RIGi,j,t = CGMi,j,peakt − CGMi,j,0TDmeal−to−peak (3)
whereCGMi,j,peakt is the highest CGMdata point between
the time of the jth meal announcement of the ith CGM
time series and prediction time t, CGMi,j,0 is a CGM data
Seo et al. BMCMedical Informatics and DecisionMaking          (2019) 19:210 Page 4 of 13
Table 1 Clinical characteristics of enrolled study subjects
Type-1 diabetes (55 three-day
CGM datasets in 52 patients)
Type-2 diabetes (52 three-day
CGM datasets in 52 patients)
Age (year) 40.0 (29.0-52.0) 63.5 (54.3-68.0)
Sex (male:female) 21:34* 21:31
Body weight (kg) 60.48 (52.35-69.41) 60.75 (54.60-70.37)
BMI (kg/m2) 22.85 ±3.26 24.60 ±2.62
Duration of diabetes (years) 11.0 (6.0-18.0) 19.0 (13.3-25.0)
Insulin therapy (with insulin ther-
apy: without insulin therapy)
55*:0 43:9
Insulin regimen basal:intermediate-
acting: premix:MDI:CSII
3:1:6:44:1 20:3:11:9:0
Daily insulin dose (IU/day) 42.3 ±17.7 28.6 ±18.1
Daily insulin dose per body weight
(IU/day/kg)
0.68 (0.53-0.82) 0.50 (0.30-0.60)
eGFR (ml/min/1.73m2) 83.05 (71.98-96.95) 70.40 (51.30-82.50)
End stage renal disease [n (%)] 4 (7.3) 2 (3.8)
Liber cirrhosis [n (%)] 2 (3.6) 0 (0.0)
Heart failure with reduced ejection
fraction [n (%)]
0 (0.0) 1 (1.9)
Pancreatic resection [n (%)] 2 (3.6)† 0 (0.0)
Acute infection [n (%)] 0 (0.0) 1 (1.9)
Pregnancy [n (%)] 1 (1.8) 0 (0.0)
Hemoglobin A1C (%) 7.94 ±1.13 8.31 ±1.32
C-peptide (ng/mL) 0.02 (0.02-0.15) 1.46 (0.80-2.44)
Continuous variables with normal distributions are expressed as mean ± standard deviation, whereas continuous variables with non-normal distributions were expressed as
median (interquartile range)
*Three female patients on insulin therapy were included twice because they participated twice
†One of these two patients underwent total pancreatectomy; the other went through Whipple’s operation. Abbreviations: CGM, continuous glucose monitoring; BMI, body
mass index; MDI, multiple daily injections; CSII, continuous subcutaneous insulin infusion; eGFR, estimated glomerular filtration rate
point at the jth meal announcement, and TDmeal−to−peak
is time difference between the meal announcement to the
peak. The RIG is updated until the peak CGM data point
is found after the meal announcement. If there is no peak
CGM data point, the RIG is set to 0. According to the def-
inition of the RIG, zero implies that there is no increase in
glucose after the meal.
Since the change in CGM data points is large before
hypgolycemia occurs (Fig. 1), we defined the second fea-
ture glucose rate of change (GRC) as:
GRCi,j,t = CGMi,j,t − CGMi,j,t−15 (4)
where CGMi,j,t is a CGM data point at the time of pre-
diction from the jth meal announcement of the ith CGM
time series, and CGMi,j,t−1 is the CGM data point imme-
diately prior to the time of prediction. Since the GRC
calculates the near-instantaneous changes in CGM data
points around the time of prediction, it can be used to pre-
dict hypoglycemia [26, 33]. The third feature is defined to
be the CGM data point at the time of prediction (CGMi,j,t)
from the jth meal announcement of the ith CGM time
series. To define labels, we took into account the pres-
ence of a hypoglycemia alert value [34, 35] at the 30-min
prediction horizon (i.e., CGMi,j,t+6). If CGMi,j,t+6 < 3.9
mmol/L (70 mg/dL), we set Labeli,j,t = 1. Otherwise, we
set Labeli,j,t = 0 (Fig. 2).
We obtained all available CGM data points between
5 min and 3.5 h post mealtime announcements (i.e.,
from CGMi,j,1 to CGMi,j,42). The corresponding hypo-
glycemia alert values that occur from 35 min to 4 h after
meal announcements were included (i.e., from Labeli,j,1
to Labeli,j,42). Although postprandial hypoglycemia can
occur later than 4 h after each meal, we chose the win-
dow of 35 min to 4 h after the meal because includ-
ing longer duration after the meal to this time window
decreases the prediction accuracy of the algorithm. Since
there are already well-established algorithms for predict-
ing fasting or nocturnal hypoglycemia [25, 36], a clinical
need of a dedicated algorithm for predicting postpran-
dial hypoglycemia would be most important during the
first 4 h after each meal, which is typically difficult to
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Fig. 1 Representative CGM time-series data to show different reactions of selected patients’ glucose levels after meals. Blue line: CGM time-series
data points; red line and transparent red box: CGM data point <3.9 mmol/L (70 mg/dL); magenta filled circle: CGM data point at the meal; red filled
circle: peak CGM data point after the meal; green filled circle: CGM data point at the time of prediction. Clinical explanations: a No peak of CGM data
point could occur because the patient ate a small amount of carbohydrates in the meal. b Low peak after the meal, then rapid fall in glucose could
occur because patient ate a small amount of carbohydrates in the meal. c Steep peak, then rapid fall in glucose could occur when the patient ate
foods rich in carbohydrate with high glycemic index or injected rapid-acting insulin later than he or she should have. d A rapid fall and then no peak
after the meal could occur when the insulin injected before the previous meal is still active (insulin on board)
cover using the existing nocturnal hypoglycemic pre-
diction algorithms developed in the setting of gradual
changes of blood glucose levels.
The data processing and the feature extraction were per-
formed using the following steps : First, from the ith CGM
time series, the jthmeal announcement is selected and the
CGM data points from CGMi,j,1 to CGMi,j,42 were sam-
pled. Second, from the sampled series, CGMi,j,t , RIGi,j,t ,
and GRCi,j,t features were extracted while increasing t
from 1 to 42. The label information is obtained from the
CGM data point with the 30-min prediction horizon (i.e.,
CGMi,j,t+6).
The first and second steps were repeated for 107 CGM
time series around mealtimes, and obtained samples :
D = {(CGMi,j,t ,RIGi,j,t ,GRCi,j,t , Labeli,j,t) with i =
1, ..., 107, j = 1, ...,Mi, and t = 1, ..., 42}, where Mi is the
total number of meal announcements of the ith CGM time
series. Before training our models, each feature values
extracted were normalized with a MinMax Scaler.
Models
In this study, we selected four commonly used machine
learning models with the unique data-driven feature set
to predict the occurrence of postprandial hypoglycemia at
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Fig. 2 The three features and the 30-min prediction horizon. Blue line: CGM time-series data points; red line: CGM data point <3.9 mmol/L (70
mg/dL); magenta filled circle: CGM data point at the meal; red filled circle: peak CGM data point after the meal; green filled circle: CGM data point at
the time of prediction; black arrow: rate of increase in glucose (RIG); red arrow: glucose rate of change (GRC); transparent yellow box: observational
window; transparent green box: the 30-min prediction horizon
30 min from the time of prediction. Four machine learn-
ing models were selected [28, 37]: a random forest (RF),
a support vector machine using a linear function (SVM-
LN) or a radial basis function (SVM-RBF), and a K-nearest
neighbor (KNN). Since there are few studies using a logis-
tic regression (LR) [15, 16], we additionally considered the
algorithm.
To train and evaluate each model, we used 5-fold cross-
subject validation by splitting D into train setq and
test setq for qth iteration. The train setq and the test setq
were represented as following:
1 train setq =
{(CGMi,j,t ,RIGi,j,t ,GRCi,j,t , Labeli,j,t) with i ∈
Rq, j = 1, ...,Mi, t = 1, ..., 42}, Rq is the qth training
folds.
2 test setq =
{(CGMi,j,t ,RIGi,j,t ,GRCi,j,t , Labeli,j,t) with i ∈ (Rcq ∩
total CGM dataset), j = 1, ...,Mi, t = 1, ..., 42}.
Data imbalance should be considered before training a
model with train setq. This imbalance results when the
model is mainly trained to predict a majority class and
cannot predict a minority class. It is important to pre-
dict the minority class since it is the main target in most
cases, e.g., postprandial hypoglycemia. For the model to
be trained, we chose a false-positive cost and a false-
negative cost so that it does not focus on the majority
class based on imbalanced data handling [38]. In the train-
ing, cost of false negative was determined using Eq. 5 on
train setq, cost of false-positive was set to 1, true-negative
cost and true-positive cost were set to 0.
Cost of false negative =
∑
i∈Rq
∑Mi
j=1
∑42
t=1(1 − Labeli,j,t)
∑
i∈Rq
∑Mi
j=1
∑42
t=1(Labeli,j,t)
(5)
Then, we optimized each model’s hyperparameters with
grid search. The best hyperparameters set that resulted
in the lowest cross-validation loss, were used for training.
During testing, after the jth meal announcement of the
ith CGM time series, CGMi,j,t , RIGi,j,t , and GRCi,j,t were
extracted at the time of prediction t. The features were
normalized by the MinMax Scaler trained on a train set.
The trained models predict postprandial hypoglycemia
with the features. This process was repeated for all t
increasing from 1 to 42. The number of cases that accu-
rately predicted label vs. inaccurately predicted label were
calculated for all meal announcements of the CGM time
series in the test set.
The average performance was calculated with the 5-
fold cross-subject validation on 107 CGM time series.
All training and evaluating process is summarized in the
flowchart shown in Fig. 3.
Metrics
We used four statistical metrics for evaluating the perfor-
mance of each model: the area under a curve (AUC) of a
receiver operating characteristic (ROC) curve, sensitivity,
specificity, and F1 score. The AUC for each model is inde-
pendent of cut-off values on the ROC curve and is mainly
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Fig. 3 Flowchart of the proposed approach including data-preprocessing, and how to train RF, SVM-LN, SVM-RBF, KNN, and LR. Since the 5-fold
cross-subject validation was used, training and testing models were repeated by 5 times. For each iteration, each model’s result and tuned
hyper-parameters was saved
used to compare the predictive capabilities of the models,
and the AUC is used as the main criterion for indicating
the accuracy of the model [39]. Other metrics are defined
as follows:
Sensitivity (or Recall) = TPTP + FN (6)
Specificity = TNTN + FP (7)
Precision = TPTP + FP (8)
F1 score = 2 × Precision × RecallPrecision + Recall (9)
The true positive (TP) represents the number of cases
predicted correctly to have a hypoglycemia alert value
(CGM data point <3.9 mmol/L) at 30 min from the time
of prediction and the true negative (TN) indicates the
number of cases predicted correctly to not have a hypo-
glycemia alert value at 30 min from the time of prediction.
The false positive (FP) is the number of cases predicted
falsely to have a hypoglycemia alert value at 30 min from
the time of prediction, and false negative (FN) is the num-
ber of cases predicted incorrectly to have a hypoglycemia
alert at 30 min from the time of prediction. Sensitivity
(or Recall) measures the ability of the algorithm to cor-
rectly detect hypoglycemia while specificity measures the
ability of the algorithm to correctly detect the absence
of it. F1 score is the harmonic mean of both metrics of
recall and precision. Since there is a trade-off relationship
between precision and recall, F1 score helps to consider
both metrics.
To calculate the performance of predictions, the defi-
nition of a hypoglycemic event and the definition of an
alarm as defined in [19] are used. The main difference
between our study and prior study [19] is that we only con-
sider hypoglycemic events in postprandial time interval (5
min to 4 h after a meal). A hypoglycemic event typically
has more than two consecutive hypoglycemia alert val-
ues. If the time difference between the two events is more
than 10 min (two-time steps), the two events are consid-
ered as different events. Otherwise, the two events are
merged to form the same event. In true alarm, the trained
model would predict a hypoglycemia alert value continu-
ously (more than two-time steps) within 60min before the
hypoglycemic event. The detection time (DT) is the time
between the first time of an alarm and the first time of a
hypoglycemic event. We did not consider alarms within
hypoglycemic events as described in [19], but considered
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only the first alarm within 60 min of each hypoglycemic
event.
We calculate the false alarm rate metric, which repre-
sents the false alarm ratio among the number of times a
patient is alarmed of a hypoglycemic event, as follows:
False Alarm Rate (FAR) = FPeTPe + FPe (10)
where TPe is true positive for an event and FPe is the false
positive for an event.
Results
We analyzed 107 three-day CGM datasets from
104 patients (type-1, n = 52; type-2, n = 52). In
this 107 three-day CGM datasets (99,955 CGM
data points at 5-min intervals, the average num-
ber of CGM data points per CGM time series was
934), 10.4% had a glucose level <3.9 mmol/L (70
mg/dL). After preprocessing of data, 2062 samples of
D = {(CGMi,j,t ,RIGi,j,t ,GRCi,j,t , Labeli,j,t) with i =
1, ..., 107, j = 1, ...,Mi, and t = 1, ..., 42} were included
with Lablei,j,t = 1 and remaining were samples with
Lablei,j,t = 0. The labels with Lablei,j,t = 0 amounts
to about 16.1 times the total number of samples with
Lablei,j,t = 1. This difference represents a high data imbal-
ance between the numbers of occurrence of hypoglycemia
vs nonoccurrence of hypoglycemia after mealtimes. The
total number of postprandial hypoglycemic events within
5 min to 4 h after each meal announcement was 249.
After we trained machine learning models (RF, SVM-
LN, SVM-RBF, KNN, and LR) with train setq obtained
from qth training folds, we calculated the statistical per-
formance of each model on each individual test setq. Since
the 5-fold cross-subject validation was done, 5 perfor-
mances of each model were used to determine the average
performance. The averaged results are summarized in
Table 2.
In order to identify the difference between the average
metrics of multiple models, we used statistical analysis
methods. The first way is to find models showed the high-
est metric or the lowest metric, and the second way is
to use a one-way analysis of variance (ANOVA) or the
Kruskal-Wallis Rank Sum Test for finding a significant
difference on the average of a metric of the models. We
used the one-way ANOVA only when both normality with
the Shapiro-Wilk test and homoscedasticity with Bartlett’s
test were satisfied. Otherwise, the Kruskal-Wallis Rank
Sum Test was used.
As shown in Table 2, the average AUC’s of RF, SVM-LN,
SVM-RBF, KNN, and LR were 0.966, 0.967, 0.952, 0.917
and 0.967, respectively. All five machine learning models
showed high AUC, with LR showing slightly better per-
formance compared to others, implying that the machine
learning models have high accuracy and excellent predic-
tive ability [39]. When we used the one-way ANOVA on
AUC, there is a significant difference (p <0.05). It indi-
cates that KNN shows the worst AUC. Figure 4 shows
ROC curves of the different models.
In sensitivity, LR showed the highest average sensitivity
(93.6%) and KNN showed the lowest average sensitiv-
ity (88.5%). When we used the Kruskal-Wallis Rank Sum
Test on sensitivity, there is no significant difference (p
= 0.06), but the p-value is very close to 0.05. In speci-
ficity, RF showed the highest average specificity (91.3%)
and LR showed the lowest average specificity (87.9%). In
F1 score, RF showed the highest average F1 score (0.543)
and LR showed the lowest average F1 score (0.484). In
TPe, RF showed the highest average value (30.2) and SVM-
LN showed the lowest average value (29.2). In FAR, KNN
showed the highest average FAR (0.779) and RF showed
the lowest average FAR (0.704). In DT, KNN showed the
highest DT (25.8) and LR showed the lowest DT (25.0).
With the one-way ANOVA on the metrics including sen-
sitivity, specificity, F1 score, TPe, and DT, there is no
significant difference (p >0.05). On the other hand, with
the one-way ANOVA on FAR, there is a significant differ-
ence (p = 0.046 <0.05). This indicates that RF is able to be
a good model to predict postprandial hypoglycemia.
Since clinically severe hypoglycemia (glucose level less
than 3.0 mmol/L, i.e., that is about 54 mg/dL [34])
can lead to catastrophic health issues [35], any predic-
tive model must accurately alarm this clinically signifi-
cant hypoglycemic events. To calculate the performance
of clinically-severe-hypoglycemia alarms, the number of
alarmed clinically significant hypoglycemic events was
counted for eachmodel. For example, if the alarmed hypo-
glycemic event has at least one CGM data point <3.0
mmol/L, we regard this event as an alarmed clinically
significant hypoglycemic event. On the other hand, if a
missed hypoglycemic event has at least one CGM data
point <3.0 mmol/L, we consider this event as a missed
clinically significant hypoglycemic event. With the 5-fold
cross-subject validation, the average number of the hypo-
glycemic events including at least one CGM data point
<3.0 mmol/L was 16.6. The average number of alarmed
clinically significant hypoglycemic events made by RF
was 14.4 events, by SVM-LN was 14.6 events, by SVM-
RBF was 14.2 events, by KNN was 15 events, and LR
was 14.4 events. All models alarmed clinically signifi-
cant hypoglycemic events of more than 86%. With the
one-way ANOVA on the alarmed clinically significant
hypoglycemic events, there is no significant difference (p
= 0.989).
To reveal that a part of false alarms were useful, we con-
sidered near-hypoglycemic events that includes at least
two consecutive CGM data points ≤4.4 mmol/L, i.e.,
about 80 mg/dL [40]. In other words, we counted all false
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Table 2 Average and standard deviation of metrics of models with 5-fold cross-subject validation
Model Sen (%,SD) Spe (%,SD) F1 score (SD) AUC (SD) NH (SD) TPe (SD) FAR (SD) DT (min,SD)
RF
89.6 91.3 0.543 0.966 36.4 30.2 0.704 25.5
(2.78) (2.03) (0.053) (0.007) (11.0) (8.42) (0.035) (1.97)
SVM 93.3 88.2 0.487 0.967 36.4 29.2 0.777 25.8
-LN (1.70) (2.83) (0.046) (0.007) (11.0) (8.30) (0.034) (2.12)
SVM 89.9 88.8 0.487 0.952 36.4 29.4 0.760 25.2
-RBF (8.65) (2.96) (0.062) (0.014) (11.0) (9.20) (0.038) (3.22)
KNN
88.5 89.4 0.492 0.917 36.4 29.6 0.779 25.8
(1.93) (2.09) (0.054) (0.012) (11.0) (8.73) (0.038) (3.76)
LR
93.6 87.9 0.484 0.967 36.4 29.6 0.772 25.0
(2.25) (2.95) (0.047) (0.007) (11.0) (8.71) (0.037) (2.87)
With the 5-fold cross-subject validation, average metrics were calculated using Eq 6, 7, 9, and 10 on test setq , q = 1, 2, 3, 4, 5. Since there should be at least two consecutive
predictions of a hypoglycemia alert value to make an alarm, we excluded hypoglycemic events occurring immediately after meals. Abbreviation: RF, random forest; SVM-LN,
support vector machine with a linear kernel; SVM-RBF, support vector machine with a radial basis function; KNN, K-nearest neighbor; LR, logistic regression; SD, standard
deviation; Sen, sensitivity; Spe, specificity; AUC, the area under the ROC curve; NH, the number of hypoglycemic events; FAR, false alarm rate; DT, detection time.
alarms where near-hypoglycemic events were included
within 60 min after the alarms. The 40.0% of average
false alarms of RF were related to the near-hypoglycemic
events, 28.6% of average false alarms of SVM-LN were
related to the near-hypoglycemic events, 31.3% of average
false alarms of SVM-RBF were related to the events, 29.9%
of average false alarms of KNN were related to the events,
and 29.1% of average false alarms of LR were related to
the events. With the one-way ANOVA on the percent-
age, there is a significant difference (p <0.05). This result
indicates many of false alarms made by the models were
related to the near-hypoglycemic events and also indicates
that the average false alarms of the RF was not only low-
est, but also many RF’s false alarms were associated with
the near-hypoglycemic events.
As a result, RF is better in predicting postprandial hypo-
glycemia with the high level of predictability.
We are the first to use RIG as a new feature. To val-
idate the impact of the feature, we trained another RF
considering only two features (i.e., CGM and GRC). As
a result, the RF showed 92.2 (4.11) % of the average
sensitivity, 89.1 (3.34) % of the average specificity, 0.509
(0.051) of the average F1 score, 0.961 (0.007) of the aver-
age AUC, 29.4 (9.39) of the average TPe, 0.742 (0.038)
of the average FAR, and 25.7 (2.48) min of the average
DT. When we compared the RF trained by all features
with the RF trained by two features (i.e., CGM and GRC),
there are significant differences in AUC (p = 0.033 <0.05)
and FAR (p = 0.045 <0.05) with Paired t-test. These
results establish the importance of RIG in improving the
performance.
Discussion
In this study, the contributions are three folds. First,
we verified the feasibility of the RF-based classifier
with the simple feature set for predicting postprandial
hypoglycemia. In comparing with other commonly used
machine learning models, the RF showed the best pre-
dictive capabilities with the highest average AUC and
superior statistical performance. Second, the proposed
methodology uses only a few CGM data points and simple
meal announcements. It does not require patients to man-
ually calculate and enter the complex information such
as carbohydrate intakes and insulin information. This will
minimize patients’ burdens and eventually lower the risk
of mistaking data inputs. Third, we found a unique data-
driven feature set by intensive review of patient glucose
data. The feature set includes the useful RIG (the rate of
increase of glucose after a meal) which reflects the steep
increase in a glucose level after a meal because of intake
of foods with high glycemic index or the late timing of
premeal rapid-acting insulin. Moreover, the presence of
a postprandial meal peak glucose due to a small amount
of meal and a low peak is reflected in RIG. In addition,
our study was based on quite large dataset from patients
with both types of diabetes (107 CGM cases from 104
patients including 52 people with type 1 diabetes and 52
people with type 2 diabetes), and thus we expect that our
proposed method can fit to a general case to predict and
prevent postprandial hypoglycemia.
Training models with highly imbalanced dataset is
a technically challenging task. This can cause a seri-
ous performance distortion. As mentioned in the
“Results” section, there was a high imbalance (16.1 times)
between hypoglycemia and non-hypoglycemia. This data
imbalance problem can be solved using approaches [41]
such as over/under sampling, cost-based learning, etc.
Among these approaches, we used the cost-sensitive
learning to utilize full data samples and avoid training with
redundant data samples. We have assigned different costs
between FP and TN to solve the problem of highly imbal-
anced dataset, and have trained the models to predict
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Fig. 4 ROC curves for different models. In each iteration of the 5-fold cross-subject validation, the hyper-parameters of the models were determined
by the grid search method. a ROC curves of RF. b ROC curves of SVM-LN. c ROC curves of SVM-RBF. d ROC curves of KNN. e ROC curves of LR. Each
colored dashed line represents the ROC curve of each fold. The red dash-dot line indicates a random prediction (i.e., AUC = 0.5)
more hypoglycemia. As a result, the five models showed
the high sensitivity greater than 88%, bigTPe, and the large
number of alarmed events including at least one CGM
data point <3.0 mmol/L (about 54 mg/dL), which is con-
sidered as clinically significant hypoglycemia. Although
these results have showed high FAR, many false alarms
have been found to be associated with near-hypoglycemic
events that have two consecutive CGM data points ≤4.4
mmol/L (about 80mg/dL). This means that there is a lot of
glucose fluctuations around mealtimes. Unlike nocturnal
hypoglycemia, it is because there may be unpredictable
interventions from people with diabetes in the daytime.
For example, the patients may be exercising, stressed,
or taking sugary drinks or snacks. Accurate predictions
of postprandial may require more user unfriendly man-
ual inputs, but this increases the burden on the patient
and the chance of users’ mistakes in entering informa-
tion. Thus, it is necessary to develop a system that can
automatically process the patient’s lifestyle data, or more
studies, which predict the occurrence of postprandial
hypoglycemia with only CGM measurements and easy
input, are needed.
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Our results showed that the ensemble way that uses
multiple single learners to make a decision with a voting
has the better predictability than the single model such
as SVM-LN, SVM-RBF, KNN, and LR. This implies that
the ensemble approach has better generalization capa-
bilities compared to other models on predictions of the
occurrence of postprandial hypoglycemia during various
glycemic changes which are affected by carbohydrate in a
meal and injected insulin doses. Thus, we selected RF as
our primary model to predict the occurrence of postpran-
dial hypoglycemia, and other model were used to contrast
the performance. For future advanced studies, the pro-
cess that optimizes the structure of an ensemble method
such as stacking multiple models, soft voting, and hard
voting and selects appropriate machine learning mod-
els is needed. Furthermore, it is also necessary to take
into account the computational complexity of the ensem-
ble model for working on a compact device. Although
this process may require complex procedures and lots of
time, it is expected that it will enable the development
of a model predicting more accurately the occurrence of
postprandial hypoglycemia without any manual inputs.
For patients, the extended prediction horizon is benefi-
cial because it increases the time available for a patient to
take action to prevent potential hypoglycemia. However,
it should be noted that there is a trade-off relationship
between the prediction horizon and the accuracy of a
model [42]. Generally, increasing the prediction horizon
will lower the accuracy and priority should be decided
based on clinical needs. For example, patients who want
to know the occurrence of hypoglycemia earlier, in spite of
many false alarms, will prefer a long-term prediction hori-
zon. Conversely, a short-term prediction horizon will be
preferred for patients who want to know the occurrence
of hypoglycemia with higher confidence. The primary rea-
son for choosing the 30-min prediction horizon was the
good trade-off between the prediction horizon and the
accuracy of prediction [37]. The 30-min prediction hori-
zon enabled an acceptable accuracy while providing an
effective time for correcting hypoglycemia with carbo-
hydrate ingestion or injection of glucagon. In addition,
several studies have used the 30-min prediction horizon
[17–21, 23, 37, 43] and have verified that this time is
sufficient to prevent hypoglycemia in patients [17]. There-
fore, we believe the 30-min prediction horizon used in
this study would be adequate for alarming people with
type 1 diabetes to take carbohydrate or for alarming a
bihormonal AP system to infuse glucagon, but the 30-min
prediction horizon might be inadequate for prevention of
hypoglycemia only by reduction of insulin infusion rate in
single hormone AP system.
Besides AP system, the model is also useful for stand-
alone real-time CGM device since it requires only meal-
time announcement and CGMdata for its operation.Meal
announcement is manual but can easily performed by
pressing a button on the device. In many type-1 or insulin-
treated type-2 diabetes patients, who cannot use an
insulin pump, multiple daily injection insulin therapy with
real-time CGM is a reasonable option [44]. Widespread
use of flash BG monitoring, which can replace a finger-
stick glucometer even for insulin-treated type-2 diabetes
patients. In these clinical settings, the feature of our algo-
rithm that does not require insulin dosing information
could be a benefit for patients who do not use insulin
pumps [45].
To collect three-day CGM data points from 104 peo-
ple with type 1 and type 2 diabetes, Medtronic’s CGMS
GoldTM was used. This device retrospectively calibrated
and filtered collected CGM data points at the end of the
monitoring. Thus, the collected CGM traces are smoother
than the real-time CGM traces.
It is important to acknowledge the limitations of the
study. First, tests were performed retrospectively with
107 three-day CGM datasets, and a prospective study
should be conducted to assess the clinical credibility of
the prediction algorithm. Second, 30-minute, which was
the prediction horizon, may be not an enough time to
avoid hypoglycemia without the ingestion of carbohy-
drates or injection of glucagon. Last, a patient should
announce mealtimes to operate our algorithm. Although
it adds a manual activity to the patient, it is still a much
less burdensome activity than counting carbohydrates
and entering injected insulin dose that other algorithms
require. As the next step, we will develop a meal detec-
tion algorithm by using CGM data and accumulated
patients’ mealtime information. It is expected to greatly
improve the usability of the hypoglycemia prediction
algorithm.
Conclusions
In this study, we could successfully identify hypoglycemia
using the RF-based model in the postprandial situation.
The algorithm could predict a hypoglycemia alert value
in a clinically-useful 30-min prediction horizon around
mealtimes. This proposed approach only requires CGM
data points and simple mealtime announcements, and
is less burdensome to patients than models using lots
of input information. This study not only establishes a
new methodology to predict postprandial hypoglycemia
but also verifies the feasibility of RF to accurately predict
postprandial hypoglycemia. We believe that the proposed
machine learning approach can be integrated with real-
time CGM devices and sensor-based AP system, so it will
be a great help for people with diabetes to manage their
glucose level and improve their quality of life. In the near
future, we will evaluate our algorithm on a prospective
patient population to clearly establish the clinical use of
this system.
Seo et al. BMCMedical Informatics and DecisionMaking          (2019) 19:210 Page 12 of 13
Abbreviations
AP: Artificial pancreas; CGM: Continuous glucose monitoring; CSII: Continuous
subcutaneous insulin infusion; FAR: False alarm rate; FGM: Flash glucose
monitoring; KNN: K-nearest neighbor; MDI: Multiple daily injection; RF:
Random forest; SVM-LN: Support vector machine with a linear kernel;
SVM-RBF: Support vector machine with a radial basis function
Acknowledgements
We are grateful to Min Ja Cho (Diabetes Center, Division of Endocrinology and
Metabolism, Department of Medicine, Samsung Medical Center) for her
dedication to the CGMS data collection and management.
Authors’ contributions
WS was a major contributor in writing the manuscript. WS reviewed related
works and designed the study. Also, he conducted main data mining and all
post-hoc analysis. YBL conducted data collection, and analysed and
summarized the clinical aspects of study subjects. SL conducted data
preprocessing. SMJ and YBL contributed on manuscript writing and critical
revision of the background, discussion and conclusion parts. SMJ and SMP
managed the whole process, and contributed on the final approval of
manuscript. All authors read and approved the final manuscript.
Funding
This research was supported by the Ministry of Science and ICT (MSIT), Korea,
under the ICT Consilience Creative program (IITP-2019-2011-1-00783)
supervised by the Institute for Information and communications Technology
Promotion (IITP), which provide financial support in the anlaysis and
interpretation of data, and the Basic Science Research Program through the
National Research Foundation of Korea (NRF) funded by the Ministry of
Science and ICT (NRF-2017R1A5A1015596), which provide financial support in
the anlaysis and interpretation of data. The publication of this article and
writing the manuscript were funded by the Technology Innovation Program
or Industrial Strategic Technology Development Program (20001841,
Development of System for Intelligent ContextAwareWearable Service based
on Machine Learning) funded By the Ministry of Trade, Industry and Energy
(MOTIE, Korea). The funding sources had no role in the design of the study and
data collection.
Availability of data andmaterials
The data that support the findings of this study are available from Samsung
Medical Center but restrictions apply to the availability of these data. The data
were used under license for the current study, and so are not publicly
available. Data are however available from the authors upon reasonable
request and with permission of Samsung Medical Center.
Ethics approval and consent to participate
The protocol of this study was approved by the Institutional Review Board
(IRB) of the Samsung Medical Center. The informed consent requirement for
this study was waived because the researcher only accessed the database for
analysis purposes, and all patient data were de-identified (IRB file number;
SMC 2016-05-058-001) All medical procedures were performed in accordance
with relevant guidelines and regulations. The informed consent requirement
for this study was waived by the board because the researcher only accessed
the database for analysis purposes, and all patient data were de-identified.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Received: 12 February 2019 Accepted: 21 October 2019
References
1. Nathan DM, DCCT/Edic Research Group. The diabetes control and
complications trial/epidemiology of diabetes interventions and
complications study at 30 years: overview. Diabetes Care. 2014;37:9–16.
2. Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, et al.
Nocturnal glucose control with an artificial pancreas at a diabetes camp.
N Engl J Med. 2013;368:824–33.
3. Thabit H, Tauschmann M, Allen J, Leelarathna L, Hartnell S, Wilinska M,
et al. Home Use of an Artificial Beta Cell in Type 1 Diabetes. New Engl J
Med. 2015;373:2129–40.
4. Diabetes Control and Complications Trial/Epidemiology of Diabetes
Interventions and Complications (DCCT/EDIC) Study Research Group.
Intensive diabetes treatment and cardiovascular disease in patients with
type 1 diabetes. N Engl J Med. 2005;353:2643–53.
5. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes. 2008;57:
3169–76.
6. Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Goergen LG, et al.
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes. N
Engl J Med. 2014;371:313–25.
7. Kudva YC, Carter RE, Cobelli C, Basu R, Basu A. Closed-loop artificial
pancreas systems: Physiological input to enhance next-generation
devices. Diabetes Care. 2014;37:1184–90.
8. Kovatchev B, Tamborlane WV, Cefalu WT, Cobelli C. The artificial
pancreas in 2016: A digital treatment ecosystem for diabetes. Diabetes
Care. 2016;39(7):1123–26. https://doi.org/10.2337/dc16-0824.
9. Bergenstal RM, Garg S, Weinzimer SA, Buckingham BA, Bode BW,
Tamborlane WV, et al. Safety of a Hybrid Closed-Loop Insulin Delivery
System in Patients With Type 1 Diabetes. JAMA. 2016;316:1407.
10. Rylander D. Glucagon in the Artificial Pancreas: Supply and Marketing
Challenges. J Diabetes Sci Technol. 2015;9(1):52–55. https://doi.org/10.
1177/1932296814546668.
11. Pohl R, Li M, Krasner A, De Souza E. Development of stable liquid
glucagon formulations for use in artificial pancreas. J Diabetes Sci
Technol. 2015;8(1):8–16.
12. Haidar A, Rabasa-Lhoret R, Legault L, Lovblom LE, Rakheja R, Messier V,
D’Aoust É, Falappa CM, Justice T, Orszag A. Single- and dual-hormone
artificial pancreas for overnight glucose control in type 1 diabetes. J Clin
Endocrinol Metab. 2016;101(1):214–23.
13. Home PD. Plasma insulin profiles after subcutaneous injection: How close
can we get to physiology in people with diabetes? Diabetes Obes Metab.
2015;17(11):1011–20. https://doi.org/10.1111/dom.12501.
14. Unger RH, Orci L. Paracrinology of islets and the paracrinopathy of
diabetes. Proc Natl Acad Sci. 2010;107:16009–12.
15. Oviedo S, Vehi J, Calm R, Armengol J. A review of personalized blood
glucose prediction strategies for T1DM patients. Int J Numer Method
Biomed Eng. 2017;33(6):1–21.
16. Woldaregay AZ, Årsand E, Botsis T, Albers D, Mamykina L, Hartvigsen G.
Data-Driven Blood Glucose Pattern Classification and Anomalies
Detection: Machine-Learning Applications in Type 1 Diabetes. J Med
Internet Res. 21(5):e11030.
17. Sparacino G, Zanderigo F, Corazza S, Maran A, Facchinetti A, Cobelli C.
Glucose concentration can be predicted ahead in time from continuous
glucose monitoring sensor time-series. IEEE Trans Biomed Eng. 2007;54:
931–7.
18. Yang J, Li L, Shi Y, Xie X. An ARIMA Model with Adaptive Orders for
Predicting Blood Glucose Concentrations and Hypoglycemia. IEEE J
Biomed Health Inform. 2018;23(3):1251–60.
19. Turksoy K, Bayrak ES, Quinn L, Littlejohn E, Rollins D, Cinar A.
Hypoglycemia early alarm systems based on multivariable models. Ind
Eng Chem Res. 2013;52:12329–36.
20. Pérez-Gandía C, Facchinetti A, Sparacino G, Cobelli C, Gómez EJ, Rigla M,
et al. Artificial neural network algorithm for online glucose prediction from
continuous glucose monitoring. Diabetes Technol Ther. 2010;12:81–8.
21. Zecchin C, Facchinetti A, Sparacino G, De Nicolao G, Cobelli C. Neural
network incorporating meal information improves accuracy of short-time
prediction of glucose concentration. IEEE Trans Biomed Eng. 2012;59:
1550–60.
22. Zecchin C, Facchinetti A, Sparacino G, De Nicolao G, Cobelli C. A new
neural network approach for short-term glucose prediction using
continuous glucose monitoring time-series and meal information. In:
Proceedings of the Annual International Conference of the IEEE
Engineering in Medicine and Biology Society, EMBS; 2011. p. 5653–6.
https://doi.org/10.1109/iembs.2011.6091368.
23. Zecchin C, Facchinetti A, Sparacino G, Cobelli C. How much is
short-term glucose prediction in type 1 diabetes improved by adding
insulin delivery and meal content information to CGM data? A
proof-of-concept study. J Diabetes Sci Technol. 2016;10:1149–60.
Seo et al. BMCMedical Informatics and DecisionMaking          (2019) 19:210 Page 13 of 13
24. Pappada SM, Cameron BD, Rosman PM, Bourey RE, Papadimos TJ, et al.
Neural network-based real-time prediction of glucose in patients with
insulin-dependent diabetes. Diabetes Technol Ther. 2011;13:135–41.
25. Dassau E, Cameron F, Lee H, Bequette BW, Zisser H, Jovanovicˇ L, et al.
Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose
Monitoring. Diabetes Care. 2010;33:1249–54.
26. Eljil KS, Qadah G, Pasquier M. Predicting hypoglycemia in diabetic
patients using data mining techniques. 2013 9th Int Conf Innov Inf
Technol. 2013130–5. https://doi.org/10.1109/innovations.2013.6544406.
27. Miyeon J, et al. Prediction of Daytime Hypoglycemic Events Using
Continuous Glucose Monitoring Data and Classification Technique. arXiv
preprint. 2017. https://arxiv.org/abs/1704.08769.
28. Sudharsan B, Peeples M, Shomali M. Hypoglycemia prediction using
machine learning models for patients with type 2 diabetes. J Diabetes Sci
Technol. 2015;9(1):86–90. https://doi.org/10.1177/1932296814554260.
29. Liebl A, Henrichs HR, Heinemann L, Freckmann G, Biermann E, Thomas
A. Continuous glucose monitoring: Evidence and consensus statement
for clinical use. J Diabetes Sci Technol. 2013;7:500–19.
30. The Diabetes Research in Children Network (DirectNet) Study Group. The
accuracy of the CGMSTM in children with type 1 diabetes: results of the
Diabetes Research in Children Network (DirecNet) accuracy study.
Diabetes Technol Ther. 2003;5(5):781–789. https://doi.org/10.1089/
152091503322526987.
31. Zhong VW, Crandell JL, Shay CM, Gordon-Larsen P, Cole SR, Juhaeri J, et al.
Dietary intake and risk of non-severe hypoglycemia in adolescents with
type 1 diabetes. J Diabetes Complicat. 2017;31(8):1340–7. https://doi.org/
10.1016/j.jdiacomp.2017.04.017.
32. Joubert M, Baillot-Rudoni S, Catargi B, Charpentier G, Esvant A, Franc S,
et al. Indication, organization, practical implementation and
interpretation guidelines for retrospective CGM recording: A French
position statement. Diabetes Metab. 2015;41(6):498–508. https://doi.org/
10.1016/j.diabet.2015.07.001.
33. Palerm CC, Willis JP, Desemone J, Bequette BW. Hypoglycemia
Prediction and Detection Using Optimal Estimation. Diabetes Technol
Ther. 2005;7:3–14.
34. American Diabetes Association. 6. Glycemic targets: standards of medical
care in diabetes—2018. Diabetes Care. 2018;41(Supplement 1):S55–64.
https://doi.org/10.2337/dc18-s006.
35. International Hypoglycaemia Study Group. Glucose concentrations of less
than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint
position statement of the American Diabetes Association and the
European Association for the Study of Diabetes. Diabetes Care. 2017;40:
155–7.
36. Schaller HC, Schaupp L, Bodenlenz M, Wilinska ME, Chassin LJ, Wach P,
et al. On-line adaptive algorithm with glucose prediction capacity for
subcutaneous closed loop control of glucose: Evaluation under fasting
conditions in patients with Type 1 diabetes. Diabet Med. 2006;23(1):90–3.
https://doi.org/10.1111/j.1464-5491.2006.01695.x.
37. Gadaleta M, Facchinetti A, Grisan E, Rossi M. Prediction of Adverse
Glycemic Events from Continuous Glucose Monitoring Signal. IEEE J
Biomed Health Inform. 2018;23(2):650–9. https://doi.org/10.1109/jbhi.
2018.2823763.
38. Ganganwar V. An overview of classification algorithms for imbalanced
datasets. J Emerg Technol Adv Eng. 2012;2:42–7.
39. Akobeng AK. Understanding diagnostic tests 3: Receiver operating
characteristic curves. Acta Paediatr Int J Paediatr. 2007;9(3):145. https://
doi.org/10.4103/picr.picr_87_18.
40. Plis K, Bunescu R, Marling C, Shubrook J, Schwartz F. A Machine
Learning Approach to Predicting Blood Glucose Levels for Diabetes
Management. In: Workshops at the Twenty-Eighth AAAI Conference on
Artific ial Intelligence: 2014; 2014.
41. Longadge R, Dongre S, Malik L. Class imbalance problem in data mining
review. 2013. arXiv preprint arXiv:13051707.
42. Palerm CC, Willis JP, Desemone J, Bequette BW. Hypoglycemia
detection and prediction using continuous glucose monitoring - A study
on hypoglycemic clamp data. J Diabetes Sci Technol. 2007;5(1):624–9.
https://doi.org/10.1177/193229680700100505.
43. Mhaskar HN, Pereverzyev SV, van der Walt MD. A deep learning
approach to diabetic blood glucose prediction. Front Appl Math Stat.
2017;3:14. https://doi.org/10.3389/fams.2017.00014.
44. Perlmuter LC, Flanagan BP, Shah PH, Singh SP. Glycemic Control and
Hypoglycemia: Is the loser the winner? Diabetes Care. 2008;31:2072–6.
45. Heinemann L, Freckmann G. CGM versus FGM; or, continuous glucose
monitoring is not flash glucose monitoring. J Diabetes Sci Technol.
2015;9(5):947–50. https://doi.org/10.1177/1932296815603528.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
